CA2561383A1 - Prophylactic and/or therapeutic agents for chronic musculoskeletal pain - Google Patents

Prophylactic and/or therapeutic agents for chronic musculoskeletal pain Download PDF

Info

Publication number
CA2561383A1
CA2561383A1 CA002561383A CA2561383A CA2561383A1 CA 2561383 A1 CA2561383 A1 CA 2561383A1 CA 002561383 A CA002561383 A CA 002561383A CA 2561383 A CA2561383 A CA 2561383A CA 2561383 A1 CA2561383 A1 CA 2561383A1
Authority
CA
Canada
Prior art keywords
substituted
prophylactic
musculoskeletal pain
therapeutic agent
diseases accompanied
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002561383A
Other languages
English (en)
French (fr)
Inventor
Hiroshi Kase
Isami Takahashi
Shunji Kunori
Minoru Kobayashi
Shizuo Shiozaki
Shiro Shirakura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyowa Kirin Co Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2561383A1 publication Critical patent/CA2561383A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
CA002561383A 2004-03-30 2005-03-30 Prophylactic and/or therapeutic agents for chronic musculoskeletal pain Abandoned CA2561383A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2004-097422 2004-03-30
JP2004097422 2004-03-30
PCT/JP2005/006033 WO2005094885A1 (ja) 2004-03-30 2005-03-30 慢性筋骨格痛を呈する疾患の予防および／または治療剤

Publications (1)

Publication Number Publication Date
CA2561383A1 true CA2561383A1 (en) 2005-10-13

Family

ID=35063534

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002561383A Abandoned CA2561383A1 (en) 2004-03-30 2005-03-30 Prophylactic and/or therapeutic agents for chronic musculoskeletal pain

Country Status (5)

Country Link
US (1) US20070149555A1 (US20070149555A1-20070628-C00038.png)
EP (1) EP1738766A4 (US20070149555A1-20070628-C00038.png)
JP (1) JPWO2005094885A1 (US20070149555A1-20070628-C00038.png)
CA (1) CA2561383A1 (US20070149555A1-20070628-C00038.png)
WO (1) WO2005094885A1 (US20070149555A1-20070628-C00038.png)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110981876A (zh) * 2018-12-21 2020-04-10 广东东阳光药业有限公司 8-取代的苯乙烯基黄嘌呤衍生物及其用途
CN111018856A (zh) * 2019-12-12 2020-04-17 广东东阳光药业有限公司 8-取代的苯乙烯基黄嘌呤衍生物及其用途
CN111072663A (zh) * 2019-12-12 2020-04-28 广东东阳光药业有限公司 8-取代的苯乙烯基黄嘌呤衍生物及其用途

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2811218B1 (fr) 2000-07-05 2003-02-28 Patrice Suslian Dispositif implantable destine a corriger l'incontinence urinaire
US8167785B2 (en) 2000-10-12 2012-05-01 Coloplast A/S Urethral support system
US20060205995A1 (en) * 2000-10-12 2006-09-14 Gyne Ideas Limited Apparatus and method for treating female urinary incontinence
GB0025068D0 (en) 2000-10-12 2000-11-29 Browning Healthcare Ltd Apparatus and method for treating female urinary incontinence
GB0108088D0 (en) 2001-03-30 2001-05-23 Browning Healthcare Ltd Surgical implant
JP4452180B2 (ja) 2002-08-02 2010-04-21 シー・アール・バード・インコーポレーテッド 女性の尿道を支持するためのシステム
GB0307082D0 (en) 2003-03-27 2003-04-30 Gyne Ideas Ltd Drug delivery device and method
GB0411360D0 (en) 2004-05-21 2004-06-23 Mpathy Medical Devices Ltd Implant
EP2170217B1 (en) 2007-06-29 2017-02-22 AMS Research Corporation Surgical articles for treating pelvic conditions
TWI473614B (zh) 2008-05-29 2015-02-21 Kyowa Hakko Kirin Co Ltd Anti-analgesic inhibitors

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5484920A (en) * 1992-04-08 1996-01-16 Kyowa Hakko Kogyo Co., Ltd. Therapeutic agent for Parkinson's disease
ATE218139T1 (de) * 1994-02-23 2002-06-15 Kyowa Hakko Kogyo Kk Xanthin-derivate
US6117878A (en) * 1998-02-24 2000-09-12 University Of Virginia 8-phenyl- or 8-cycloalkyl xanthine antagonists of A2B human adenosine receptors
US6232297B1 (en) * 1999-02-01 2001-05-15 University Of Virginia Patent Foundation Methods and compositions for treating inflammatory response
US6610324B2 (en) * 1999-04-07 2003-08-26 The Mclean Hospital Corporation Flupirtine in the treatment of fibromyalgia and related conditions
US6586413B2 (en) * 1999-11-05 2003-07-01 The United States Of America As Represented By The Department Of Health And Human Services Methods and compositions for reducing ischemic injury of the heart by administering adenosine receptor agonists and antagonists
US7189717B2 (en) * 2000-04-26 2007-03-13 Eisai Co., Ltd. Medicinal compositions promoting bowel movement
AUPR606401A0 (en) * 2001-07-02 2001-07-26 Fujisawa Pharmaceutical Co., Ltd. Pyrazolopyridine compound and pharmaceutical use thereof
EP1441732A2 (en) * 2001-11-08 2004-08-04 Fujisawa Pharmaceutical Co., Ltd. Thiazole derivative and pharmaceutical use thereof
WO2003103675A2 (en) * 2002-06-06 2003-12-18 Endacea, Inc. Combination treatments for purinoceptor-related disorders
AU2002950853A0 (en) * 2002-08-19 2002-09-12 Fujisawa Pharmaceutical Co., Ltd. Aminopyrimidine compound and pharmaceutical use thereof
DE60322067D1 (de) * 2002-08-30 2008-08-21 Kyowa Hakko Kogyo Kk Adenosin-a2a-rezeptorantagonisten zur behandlung des syndroms der unruhigen beine oder nächtlichen myoklonus
UA79011C2 (uk) * 2002-09-05 2007-05-10 Гвіда Енд К. С.П.А. Одноразовий самонагрівний або самоохолоджуваний контейнер, переважно для напоїв, та спосіб його виготовлення

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110981876A (zh) * 2018-12-21 2020-04-10 广东东阳光药业有限公司 8-取代的苯乙烯基黄嘌呤衍生物及其用途
WO2020125779A1 (en) * 2018-12-21 2020-06-25 Sunshine Lake Pharma Co., Ltd. 8-substituted styryl xanthine derivatives and uses thereof
CN110981876B (zh) * 2018-12-21 2021-10-01 广东东阳光药业有限公司 8-取代的苯乙烯基黄嘌呤衍生物及其用途
CN111018856A (zh) * 2019-12-12 2020-04-17 广东东阳光药业有限公司 8-取代的苯乙烯基黄嘌呤衍生物及其用途
CN111072663A (zh) * 2019-12-12 2020-04-28 广东东阳光药业有限公司 8-取代的苯乙烯基黄嘌呤衍生物及其用途
CN111072663B (zh) * 2019-12-12 2021-10-01 广东东阳光药业有限公司 8-取代的苯乙烯基黄嘌呤衍生物及其用途
CN111018856B (zh) * 2019-12-12 2021-10-01 广东东阳光药业有限公司 8-取代的苯乙烯基黄嘌呤衍生物及其用途

Also Published As

Publication number Publication date
JPWO2005094885A1 (ja) 2007-08-16
US20070149555A1 (en) 2007-06-28
EP1738766A4 (en) 2010-05-12
EP1738766A1 (en) 2007-01-03
WO2005094885A1 (ja) 2005-10-13

Similar Documents

Publication Publication Date Title
CA2561383A1 (en) Prophylactic and/or therapeutic agents for chronic musculoskeletal pain
US7851478B2 (en) Agent for preventing and/or treating movement disorder
US20120232089A1 (en) Method of treating an anxiety disorder
RU2221563C2 (ru) Фармацевтическая композиция для лечения болезни паркинсона и синдромов паркинсона, способ ее получения, способ лечения болезни паркинсона и синдромов паркинсона
RU2561871C2 (ru) Антагонист опиоидных рецепторов (налтрексон) для использования в терапии герпесного опоясывающего лишая
EP1534289B1 (en) Adenosine a2a receptor antagonists for treating restless legs syndrome or nocturnal myoclonus
JP5188066B2 (ja) 薬物依存症の予防および／または治療剤
JP2003327529A (ja) 鎮咳薬および該鎮咳薬を含有する医薬組成物
CA2554426C (en) Agents for treating migraine
US20060205756A1 (en) Antitussives
JPH02223523A (ja) 不安及び不眠症の治療のための薬剤
WO1999030715A1 (fr) Agents prophylactiques contre les troubles du sommeil et remedes aux troubles du sommeil
MXPA06005965A (en) Preventive and/or therapeutic agent for higher brain dysfunction
AU2004296137A1 (en) Preventive and/or therapeutic agent for higher brain dysfunction

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead